# Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program

> **NCT02422602** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 196 (actual)

## Conditions studied

- Non-valvular Atrial Fibrillation

## Interventions

- **DRUG:** Xarelto
- **OTHER:** Experimental: Personalized information intervention

## Key facts

- **NCT ID:** NCT02422602
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-26
- **Primary completion:** 2015-05-06
- **Final completion:** 2016-05-06
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2021-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02422602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02422602, "Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02422602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*